Clinical evaluation of the enhancement of vagal tone in acute myocardial infarction by edrophonium hydrochloride

Effects on ventricular arrhythmias, His bundle electrography, and left ventricular function

Richard R. Miller, Harold G. Olson, Zakauddin Vera, Anthony N. DeMaria, Ezra A Amsterdam, Dean T. Mason

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Enhanced electrical stability of acutely ischemic myocardium with vagal stimulation and acetylcholinesterase inhibition has been demonstrated experimentally. To extend these findings clinically, within 24 hours of acute myocardial infarction, 11 patients underwent continuous 10 hour Holter monitoring: 2.5 hour control before and after 5 hour constant edrophonium infusion (0.25 to 2.00 mg./minute). Continuous infusion of the agent lowered heart rate 92 to 78 b.p.m. (p<0.01). Although mean total ventricular extrasystoles (PVC's) per 5 hours per patient (131) and PVC's per 1,000 beats (4.7) were unchanged (p>0.05), potentially lethal tachyarrhythmias (malignant PVC's: multifocal, R on T, paired, >5 per minute or ventricular tachycardia) were terminated in six of 10 patients by edrophonium. However, serious ventricular arrhythmias continued in three patients and appeared in four despite the agent. Ventricular fibrillation did not occur during the 10 hour period of study. In addition, the patients were evaluated hemodynamically and by His bundle electrograms before and after a 10 mg. bolus of edrophonium prior to the 10 hour constant infusion: heart rate declined (88 to 72 b.p.m., p<0.01), while mean arterial pressure (98 mm. Hg), left ventricular filling pressure (14 mm. Hg), cardiac index (2.4 L. per minute per square meter), and stroke work index (36 Gm.m./M.2) were unchanged (p>0.05). The edrophonium bolus prolonged the A-H interval (117 to 135 msec., p<0.01) while the H-Q interval was unaltered (48 msec.; p>0.05). It is concluded that increased vagal tone with edrophonium did not reduce the over-all presence of premature ventricular contractions in the entire study group; however, the malignant nature of PVC's and ventricular tachycardia appeared to be lessened by the parasympathomimetic agent in certain patients. In addition, no adverse hemodynamic or intraventricular conduction effects were produced by edrophonium administration.

Original languageEnglish (US)
Pages (from-to)222-228
Number of pages7
JournalAmerican Heart Journal
Volume93
Issue number2
DOIs
StatePublished - 1977

Fingerprint

Edrophonium
Bundle of His
Left Ventricular Function
Cardiac Arrhythmias
Myocardial Infarction
Ventricular Tachycardia
Polyvinyl Chloride
Parasympathomimetics
Heart Rate
Cardiac Electrophysiologic Techniques
Ambulatory Electrocardiography
Ventricular Premature Complexes
Ventricular Fibrillation
Acetylcholinesterase
Tachycardia
Myocardium
Hemodynamics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical evaluation of the enhancement of vagal tone in acute myocardial infarction by edrophonium hydrochloride : Effects on ventricular arrhythmias, His bundle electrography, and left ventricular function. / Miller, Richard R.; Olson, Harold G.; Vera, Zakauddin; DeMaria, Anthony N.; Amsterdam, Ezra A; Mason, Dean T.

In: American Heart Journal, Vol. 93, No. 2, 1977, p. 222-228.

Research output: Contribution to journalArticle

@article{cc0e233121f341bfb11a4df3a4280d2c,
title = "Clinical evaluation of the enhancement of vagal tone in acute myocardial infarction by edrophonium hydrochloride: Effects on ventricular arrhythmias, His bundle electrography, and left ventricular function",
abstract = "Enhanced electrical stability of acutely ischemic myocardium with vagal stimulation and acetylcholinesterase inhibition has been demonstrated experimentally. To extend these findings clinically, within 24 hours of acute myocardial infarction, 11 patients underwent continuous 10 hour Holter monitoring: 2.5 hour control before and after 5 hour constant edrophonium infusion (0.25 to 2.00 mg./minute). Continuous infusion of the agent lowered heart rate 92 to 78 b.p.m. (p<0.01). Although mean total ventricular extrasystoles (PVC's) per 5 hours per patient (131) and PVC's per 1,000 beats (4.7) were unchanged (p>0.05), potentially lethal tachyarrhythmias (malignant PVC's: multifocal, R on T, paired, >5 per minute or ventricular tachycardia) were terminated in six of 10 patients by edrophonium. However, serious ventricular arrhythmias continued in three patients and appeared in four despite the agent. Ventricular fibrillation did not occur during the 10 hour period of study. In addition, the patients were evaluated hemodynamically and by His bundle electrograms before and after a 10 mg. bolus of edrophonium prior to the 10 hour constant infusion: heart rate declined (88 to 72 b.p.m., p<0.01), while mean arterial pressure (98 mm. Hg), left ventricular filling pressure (14 mm. Hg), cardiac index (2.4 L. per minute per square meter), and stroke work index (36 Gm.m./M.2) were unchanged (p>0.05). The edrophonium bolus prolonged the A-H interval (117 to 135 msec., p<0.01) while the H-Q interval was unaltered (48 msec.; p>0.05). It is concluded that increased vagal tone with edrophonium did not reduce the over-all presence of premature ventricular contractions in the entire study group; however, the malignant nature of PVC's and ventricular tachycardia appeared to be lessened by the parasympathomimetic agent in certain patients. In addition, no adverse hemodynamic or intraventricular conduction effects were produced by edrophonium administration.",
author = "Miller, {Richard R.} and Olson, {Harold G.} and Zakauddin Vera and DeMaria, {Anthony N.} and Amsterdam, {Ezra A} and Mason, {Dean T.}",
year = "1977",
doi = "10.1016/S0002-8703(77)80315-3",
language = "English (US)",
volume = "93",
pages = "222--228",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Clinical evaluation of the enhancement of vagal tone in acute myocardial infarction by edrophonium hydrochloride

T2 - Effects on ventricular arrhythmias, His bundle electrography, and left ventricular function

AU - Miller, Richard R.

AU - Olson, Harold G.

AU - Vera, Zakauddin

AU - DeMaria, Anthony N.

AU - Amsterdam, Ezra A

AU - Mason, Dean T.

PY - 1977

Y1 - 1977

N2 - Enhanced electrical stability of acutely ischemic myocardium with vagal stimulation and acetylcholinesterase inhibition has been demonstrated experimentally. To extend these findings clinically, within 24 hours of acute myocardial infarction, 11 patients underwent continuous 10 hour Holter monitoring: 2.5 hour control before and after 5 hour constant edrophonium infusion (0.25 to 2.00 mg./minute). Continuous infusion of the agent lowered heart rate 92 to 78 b.p.m. (p<0.01). Although mean total ventricular extrasystoles (PVC's) per 5 hours per patient (131) and PVC's per 1,000 beats (4.7) were unchanged (p>0.05), potentially lethal tachyarrhythmias (malignant PVC's: multifocal, R on T, paired, >5 per minute or ventricular tachycardia) were terminated in six of 10 patients by edrophonium. However, serious ventricular arrhythmias continued in three patients and appeared in four despite the agent. Ventricular fibrillation did not occur during the 10 hour period of study. In addition, the patients were evaluated hemodynamically and by His bundle electrograms before and after a 10 mg. bolus of edrophonium prior to the 10 hour constant infusion: heart rate declined (88 to 72 b.p.m., p<0.01), while mean arterial pressure (98 mm. Hg), left ventricular filling pressure (14 mm. Hg), cardiac index (2.4 L. per minute per square meter), and stroke work index (36 Gm.m./M.2) were unchanged (p>0.05). The edrophonium bolus prolonged the A-H interval (117 to 135 msec., p<0.01) while the H-Q interval was unaltered (48 msec.; p>0.05). It is concluded that increased vagal tone with edrophonium did not reduce the over-all presence of premature ventricular contractions in the entire study group; however, the malignant nature of PVC's and ventricular tachycardia appeared to be lessened by the parasympathomimetic agent in certain patients. In addition, no adverse hemodynamic or intraventricular conduction effects were produced by edrophonium administration.

AB - Enhanced electrical stability of acutely ischemic myocardium with vagal stimulation and acetylcholinesterase inhibition has been demonstrated experimentally. To extend these findings clinically, within 24 hours of acute myocardial infarction, 11 patients underwent continuous 10 hour Holter monitoring: 2.5 hour control before and after 5 hour constant edrophonium infusion (0.25 to 2.00 mg./minute). Continuous infusion of the agent lowered heart rate 92 to 78 b.p.m. (p<0.01). Although mean total ventricular extrasystoles (PVC's) per 5 hours per patient (131) and PVC's per 1,000 beats (4.7) were unchanged (p>0.05), potentially lethal tachyarrhythmias (malignant PVC's: multifocal, R on T, paired, >5 per minute or ventricular tachycardia) were terminated in six of 10 patients by edrophonium. However, serious ventricular arrhythmias continued in three patients and appeared in four despite the agent. Ventricular fibrillation did not occur during the 10 hour period of study. In addition, the patients were evaluated hemodynamically and by His bundle electrograms before and after a 10 mg. bolus of edrophonium prior to the 10 hour constant infusion: heart rate declined (88 to 72 b.p.m., p<0.01), while mean arterial pressure (98 mm. Hg), left ventricular filling pressure (14 mm. Hg), cardiac index (2.4 L. per minute per square meter), and stroke work index (36 Gm.m./M.2) were unchanged (p>0.05). The edrophonium bolus prolonged the A-H interval (117 to 135 msec., p<0.01) while the H-Q interval was unaltered (48 msec.; p>0.05). It is concluded that increased vagal tone with edrophonium did not reduce the over-all presence of premature ventricular contractions in the entire study group; however, the malignant nature of PVC's and ventricular tachycardia appeared to be lessened by the parasympathomimetic agent in certain patients. In addition, no adverse hemodynamic or intraventricular conduction effects were produced by edrophonium administration.

UR - http://www.scopus.com/inward/record.url?scp=0017339026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017339026&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(77)80315-3

DO - 10.1016/S0002-8703(77)80315-3

M3 - Article

VL - 93

SP - 222

EP - 228

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2

ER -